Synthesis and Antifungal Activities of (2R, 3R)-2-Aryl-1-azolyl-3-(substituted amino)-2-butanol Derivatives as Topical Antifungal Agents
スポンサーリンク
概要
- 論文の詳細を見る
2-Aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives I were prepared by ring-opening reaction of epoxides II with excess amine, and their antifungal activities were evaluated as topical agents. Azolyl-cyclic amine derivatives with a methylene group showed extremely strong activity with a broad spectrum in vitro. In general, anti-Trichophyton mentagrophytes activities of most of the topical antifungal agents are substantially reduced by addition of keratin (a major constituent of the keratinized tissue). However, the triazole derivative (2R, 3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidino)-1-(1H-1,2,4-triazol-1-yl)-2-butanol ((-)-40,KP-103) showed very little deactivation by addition of keratin. This biological characteristic of triazole derivative (-)-40 resulted in excellent therapeutic efficacy on dermatophytosis superior to that of the corresponding imidazole derivative ((-)-41).
- 公益社団法人日本薬学会の論文
- 1999-10-15
著者
-
Tatsumi Yasuaki
Department Of Legal Medicine Kanazawa University School Of Medicine
-
Tatsumi Yasuaki
Department Of Medical Technology Nagoya University School Of Health Sciences
-
Nishida T
Yamaguchi Prefectural Res. Inst. Health Yamaguchi Jpn
-
Tatsumi Y
Department Of Medical Technology Nagoya University School Of Health Sciences
-
Arika T
Kaken Pharmaceutical Co. Ltd. Shizuoka Jpn
-
OGURA Hironobu
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
KOBAYASHI Haruhito
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
NAGAI Kiyoshi
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
NISHIDA Tokiko
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
NAITO Takanobu
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
TATSUMI Yoshiyuki
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
YOKOO Mamoru
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
ARIKA Tadashi
Development Research Laboratories, Kaken Pharmaceutical Co., Ltd.,
-
Yokoo Mamoru
Central Research Laboratories Kaken Pharmaceutical Co. Lid.
-
Nagai K
Development Research Laboratories Kaken Pharmaceutical Co. Ltd.
-
Naito Takanobu
Development Research Laboratories Kaken Pharmaceutical Co. Ltd.
-
Kobayashi Haruhito
Development Research Laboratories Kaken Pharmaceutical Co. Ltd.
-
Tatsumi Y
Kyoto Univ. Beppu Jpn
-
Ogura H
Development Research Laboratories Kaken Pharmaceutical Co. Ltd.
関連論文
- Adhesive Interaction of Highly Malignant Hepatoma AH66F Cells with Mesothelial Cells
- Special stain and X-ray probe microanalysis of livers with Wilson disease
- In vivo Cisplatin Resistance Depending upon Canalicular Multispecific Organic Anion Transporter (cMOAT)
- Selective Phosphodiesterase Type 4 Inhibitors Reduce the Prolonged Survival of Eosinophils Stimulated by Granulocyte-Macrophage Colony-Stimulating Factor
- Induction of Histamine Release from Rat Peritoneal Mast Cells by Histatins
- Antipyretic Activity of Gingyo-san, a Traditional Medicine, in Influenza Virus-Infected Mice
- Efficacy of Kampo medicines on cutaneous herpes simplex virus type 1 infection in mice
- In Vivo Fungicidal Effect of KP-103 in a Guinea Pig Model of Interdigital Tinea Pedis Determined by Using s New Method for Removing the Antimycotic Carryover Effect
- KP-103, Novel Triazole Derivative, Is Effective in Preventing Relapse and Successfully Treating Experimental Interdigital Tinea Pedis and Tinea Corporis in Guinea Pigs
- Synthesis and Antifungal Activities of (2R, 3R)-2-Aryl-1-azolyl-3-(substituted amino)-2-butanol Derivatives as Topical Antifungal Agents
- The behaviour of platinum-group elements during magmatic differentiation in Hawaiian tholeiites
- Patients with Chronic Hepatitis C May be More Sensitive to Iron Hepatotoxicity than Patients with HFE-Hemochromatosis
- Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders
- Osmium concentrations and ^Os/^Os ratios of GSJ reference samples, JB-1a, JA-2 and JP-1
- Liver structures of a patient with idiopathic copper toxicosis
- Current state of Wilson disease patients in central Japan
- Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overload
- Potential of the international scoring system for the diagnosis of Wilson disease to differentiate Japanese patients who need anti-copper treatment